Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Donepezil in patients with severe Alzheimer's disease: double-blind parallel-group, placebo controlled study.

× No keyword cloud information.

5 in total

1. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.

Authors: H Feldman; S Gauthier; J Hecker; B Vellas; P Subbiah; E Whalen
Journal: Neurology Date: 2001-08-28 Impact factor: 9.910

2. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Authors: P N Tariot; J L Cummings; I R Katz; J Mintzer; C A Perdomo; E M Schwam; E Whalen
Journal: J Am Geriatr Soc Date: 2001-12 Impact factor: 5.562

3. Memantine in moderate-to-severe Alzheimer's disease.

Authors: Barry Reisberg; Rachelle Doody; Albrecht Stöffler; Frederick Schmitt; Steven Ferris; Hans Jörg Möbius
Journal: N Engl J Med Date: 2003-04-03 Impact factor: 91.245

4. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.

Authors: Howard Feldman; Serge Gauthier; Jane Hecker; Bruno Vellas; Yikang Xu; John R Ieni; Elias M Schwam
Journal: Int J Geriatr Psychiatry Date: 2005-06 Impact factor: 3.485

5. Economic evaluation of donepezil in moderate to severe Alzheimer disease.

Authors: H Feldman; S Gauthier; J Hecker; B Vellas; M Hux; Y Xu; E M Schwam; S Shah; V Mastey
Journal: Neurology Date: 2004-08-24 Impact factor: 9.910

5 in total

1 in total

Review 1. Donepezil for dementia due to Alzheimer's disease.

Authors: Jacqueline S Birks; Richard J Harvey
Journal: Cochrane Database Syst Rev Date: 2018-06-18

1 in total